Position in NVO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$131,197,254
+$114,642,702 QoQ
Shares Held
2,736,697
+507.5% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#32
of 1,348 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $3,615,172,375 across 15 Drug Manufacturers - General names. NVO ranks #8 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
11,593,352 | $668,008,942 | |
| 2 | LLY |
ELI LILLY & Co
|
508,522 | $609,936,593 | |
| 3 | ABBV |
AbbVie Inc.
|
1,901,997 | $478,618,525 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,695,329 | $474,849,776 | |
| 5 | AZN |
Astrazeneca PLC
|
2,262,369 | $428,990,409 | |
| 6 | GSK |
GSK plc
|
6,660,434 | $349,139,950 | |
| 7 | JNJ |
Johnson & Johnson
|
1,361,700 | $345,830,949 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
2,736,697 | $131,197,254 |
All Filings in NVO
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $131,197,254 | 2,736,697 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $16,554,552 | 450,464 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $4,565,411 | 89,729 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $12,162,520 | 219,184 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $23,162,214 | 335,587 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $72,541,051 | 1,044,658 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $560,936 | 6,521 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $17,820,016 | 149,660 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $49,952,433 | 349,954 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $159,746,035 | 1,244,128 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $9,187,911 | 88,815 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $532,180 | 5,852 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,406,950 | 8,694 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $723,291 | 4,545 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $1,190,721 | 8,798 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $981,654 | 9,853 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,097,919 | 9,853 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $1,094,175 | 9,853 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $1,301,664 | 11,622 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $1,131,381 | 11,784 | Shares | Defined | 2021-11-12 | |
| 2020-12-31 | $1,226,496 | 17,559 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,219,746 | 17,568 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $1,150,352 | 17,568 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $976,504 | 16,221 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||